BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26062577)

  • 1. β-elemene enhances both radiosensitivity and chemosensitivity of glioblastoma cells through the inhibition of the ATM signaling pathway.
    Liu S; Zhou L; Zhao Y; Yuan Y
    Oncol Rep; 2015 Aug; 34(2):943-51. PubMed ID: 26062577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Elemene inhibits proliferation through crosstalk between glia maturation factor β and extracellular signal‑regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells.
    Zhu TZ; Li XM; Luo LH; Xu YH; Cao P; Liu Y; Liang GB
    Mol Med Rep; 2014 Aug; 10(2):1122-8. PubMed ID: 24866280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway.
    Mu L; Wang T; Chen Y; Tang X; Yuan Y; Zhao Y
    Int J Oncol; 2016 Oct; 49(4):1427-36. PubMed ID: 27498706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of the effects of a sphingosine kinase inhibitor to temozolomide and radiation treatment on glioblastoma cell lines.
    Oancea-Castillo LR; Klein C; Abdollahi A; Weber KJ; Régnier-Vigouroux A; Dokic I
    Cancer Biol Ther; 2017 Jun; 18(6):400-406. PubMed ID: 28494176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells.
    Zhu TZ; Li XM; Luo LH; Song ZQ; Gao X; Li ZQ; Su JY; Liang GB
    Int J Oncol; 2014 Aug; 45(2):699-709. PubMed ID: 24841897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
    Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
    Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation.
    Liu JS; Che XM; Chang S; Qiu GL; He SC; Fan L; Zhao W; Zhang ZL; Wang SF
    World J Gastroenterol; 2015 Sep; 21(34):9945-56. PubMed ID: 26379399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mangiferin induces radiosensitization in glioblastoma cells by inhibiting nonhomologous end joining.
    Mu F; Liu T; Zheng H; Xie X; Lei T; He X; Du S; Tong R; Wang Y
    Oncol Rep; 2018 Dec; 40(6):3663-3673. PubMed ID: 30272350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Elemene radiosensitizes lung cancer A549 cells by enhancing DNA damage and inhibiting DNA repair.
    Li LJ; Zhong LF; Jiang LP; Geng CY; Zou LJ
    Phytother Res; 2011 Jul; 25(7):1095-7. PubMed ID: 22692988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control.
    Golding SE; Rosenberg E; Adams BR; Wignarajah S; Beckta JM; O'Connor MJ; Valerie K
    Cell Cycle; 2012 Mar; 11(6):1167-73. PubMed ID: 22370485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells.
    Atif F; Patel NR; Yousuf S; Stein DG
    PLoS One; 2015; 10(6):e0131441. PubMed ID: 26110872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
    Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
    Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversion of malignant phenotypes of human glioblastoma cells by β-elemene through β-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules.
    Zhu T; Li X; Luo L; Wang X; Li Z; Xie P; Gao X; Song Z; Su J; Liang G
    J Transl Med; 2015 Nov; 13():356. PubMed ID: 26563263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-elemene inhibits proliferation of human glioblastoma cells through the activation of glia maturation factor β and induces sensitization to cisplatin.
    Zhu T; Xu Y; Dong B; Zhang J; Wei Z; Xu Y; Yao Y
    Oncol Rep; 2011 Aug; 26(2):405-13. PubMed ID: 21519795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of peroxiredoxin-1 by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenografts.
    Li G; Xie B; Li X; Chen Y; Xu Y; Xu-Welliver M; Zou L
    Oncol Rep; 2015 Mar; 33(3):1427-33. PubMed ID: 25607351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells.
    Wong ST; Zhang XQ; Zhuang JT; Chan HL; Li CH; Leung GK
    Anticancer Res; 2012 Jul; 32(7):2835-41. PubMed ID: 22753745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro responsiveness of glioma cell lines to multimodality treatment with radiotherapy, temozolomide, and epidermal growth factor receptor inhibition with cetuximab.
    Combs SE; Schulz-Ertner D; Roth W; Herold-Mende C; Debus J; Weber KJ
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):873-82. PubMed ID: 17544000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of survivin and hypoxia-inducible factor-1 α by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenograft.
    Li G; Xie B; Li X; Chen Y; Wang Q; Xu Y; Xu-Welliver M; Zou L
    Cancer Biother Radiopharm; 2012 Feb; 27(1):56-64. PubMed ID: 22248028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation.
    Yao YQ; Ding X; Jia YC; Huang CX; Wang YZ; Xu YH
    Cancer Lett; 2008 Jun; 264(1):127-34. PubMed ID: 18442668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.